IRAK2 Knockout HAP1 Cell Line

The choice depends on whether you are studying IRAK2 (interleukin-1 receptor-associated kinase 2)'s role as a MyD88-dependent signaling adapter or its functions in sustained NF-κB and JNK activation downstream of TLRs and IL-1R. The Knockout line is the standard tool for asking whether IRAK2 is required for these processes — IRAK family kinases (IRAK1, IRAK2, IRAK4, IRAK-M/IRAK3) act sequentially in the Myddosome complex: IRAK4 phosphorylates IRAK1 (acute response) and IRAK2 (sustained response), with IRAK2 important for late-phase NF-κB activation. Overexpression is useful for studying IRAK2 in heterologous expression contexts. Important consideration: IRAK2 is a pseudokinase or very weakly active kinase — its scaffolding function may be more critical than catalytic activity. Rescue with wild-type or kinase-domain-mutant IRAK2 is the standard specificity control. The knockout is valuable for studying TLR/IL-1R signaling kinetics and the IRAK1-acute / IRAK2-sustained signaling paradigm; emerging IRAK4 inhibitors (zimlovisertib, KT-474) and IRAK4 degraders may differentially affect IRAK1 versus IRAK2 phosphorylation.

Primary applications: • Sustained NF-κB activation: temporal phospho-IKK and phospho-IκBα analysis to characterize IRAK2's contribution to late-phase NF-κB signaling distinct from IRAK1's acute role. • TLR/IL-1R signaling kinetics: time-course analysis of MyD88-dependent signaling following LPS, IL-1β, or other TLR/IL-1R stimulation. • IRAK family comparative studies: IRAK1, IRAK4, IRAK-M expression analysis to interpret IRAK2-specific functions. • IRAK4 inhibitor mechanism: zimlovisertib, KT-474, and other IRAK4 inhibitor/degrader effects on IRAK1 versus IRAK2 phosphorylation in MyD88-dependent signaling. EDITGENE recommends this model for researchers investigating IRAK family signaling and the acute/sustained NF-κB regulation paradigm.

Yes. IRAK2 rescue experiments require attention to MyD88-Myddosome architecture: • Construct design: use a codon-modified IRAK2 sequence with a small C-terminal tag (FLAG, HA). IRAK2 has N-terminal death domain (Myddosome binding) and central pseudokinase/very weak kinase domain — preserve all elements. • Death-domain-mutant rescue: death domain mutations disrupt Myddosome assembly. • Scaffolding vs catalytic dissection: kinase-domain mutations enable separation of any kinase function from scaffolding. • Functional readout: rescue should restore sustained NF-κB activation following TLR/IL-1R stimulation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.